SEC Form 4 · accession 0001017491-17-000101
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Dorsey
Officer — SVP, Chief Development Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2017 | F | 14,093 | $1.56 | D | 164,601 | D |
Table II — derivative securities
No Table II lines on this filing.